INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,680,968 | +19.7% | 66,573 | 0.0% | 0.11% | +113.7% |
| Q2 2023 | $1,404,690 | +23.8% | 66,573 | 0.0% | 0.05% | +96.2% |
| Q1 2023 | $1,135,070 | -34.4% | 66,573 | -23.1% | 0.03% | -13.3% |
| Q4 2022 | $1,730,308 | +167.0% | 86,602 | +187.9% | 0.03% | +172.7% |
| Q3 2022 | $648,000 | -58.2% | 30,085 | -54.4% | 0.01% | -63.3% |
| Q1 2022 | $1,550,000 | +68.5% | 65,971 | +95.3% | 0.03% | +25.0% |
| Q4 2021 | $920,000 | -6.2% | 33,786 | -5.2% | 0.02% | +33.3% |
| Q3 2021 | $981,000 | +10.0% | 35,629 | +13.6% | 0.02% | +12.5% |
| Q2 2021 | $892,000 | -13.6% | 31,358 | +3.4% | 0.02% | -11.1% |
| Q1 2021 | $1,033,000 | +64.2% | 30,320 | +60.4% | 0.02% | +63.6% |
| Q4 2020 | $629,000 | +3.6% | 18,900 | 0.0% | 0.01% | -38.9% |
| Q3 2020 | $607,000 | +23.9% | 18,900 | +6.2% | 0.02% | -21.7% |
| Q2 2020 | $490,000 | – | 17,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |